Strs Ohio Axonics, Inc. Transaction History

Strs Ohio

$24.9 Billion
Q2 2024

A detailed history of Strs Ohio transactions in Axonics, Inc. stock. As of the latest transaction made, Strs Ohio holds 4,700 shares of AXNX stock, worth $326,415. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,700

Previous 4,700 -0.0%

Holding current value

$326,415

Previous $324,000 2.78%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$56.67 - $69.36 $17,001 - $20,808	-300 Reduced 6.0%	4,700 $324,000
Q4 2023 Jan 30, 2024	SELL	$49.38 - $63.75 $69,132 - $89,250	-1,400 Reduced 21.88%	5,000 $311,000
Q3 2023 Oct 26, 2023	SELL	$48.64 - $62.51 $549,632 - $706,363	-11,300 Reduced 63.84%	6,400 $359,000
Q2 2023 Jul 31, 2023	SELL	$47.99 - $60.21 $9,598 - $12,042	-200 Reduced 1.12%	17,700 $893,000
Q1 2023 Aug 02, 2023	BUY	$52.6 - $67.34 $10,520 - $13,468	200 Added 1.13%	17,900 $976,000
Q4 2022 Jan 26, 2023	BUY	$59.56 - $76.6 $136,988 - $176,180	2,300 Added 14.74%	17,900 $1.12 Million
Q3 2022 Oct 27, 2022	BUY	$57.96 - $78.12 $857,808 - $1.16 Million	14,800 Added 1850.0%	15,600 $1.1 Million
Q2 2022 Jul 25, 2022	BUY	$39.5 - $64.42 $31,600 - $51,536	800 New	800 $45,000
Q4 2021 Jan 24, 2022	SELL	$50.01 - $73.35 $50,010 - $73,350	-1,000 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$59.21 - $78.66 $59,210 - $78,660	1,000 New	1,000 $65,000
Q3 2019 Oct 21, 2019	SELL	$26.92 - $42.41 $110,372 - $173,881	-4,100 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$18.54 - $40.97 $40,788 - $90,134	2,200 Added 115.79%	4,100 $167,000
Q4 2018 Jan 23, 2019	BUY	$13.2 - $16.43 $25,080 - $31,217	1,900 New	1,900 $28,000

Others Institutions Holding AXNX

# of Institutions

241

Shares Held

42.8M

Call Options Held

73.7K

Put Options Held

230K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.41B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account